Rituxan (Rituximab): Uses, Dosage, Side Effects, Interactions, Warning
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating
PV | RITUXAN® (rituximab) Dosing & Infusion Resources
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study | BMC Musculoskeletal Disorders | Full Text
VisualAbstract: Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression | 2 Minute Medicine
RA | RITUXAN® (rituximab) Infusions & Dosing Schedule
RA | RITUXAN® (rituximab) Infusion Steps & Resources
Should You Get the COVID-19 Vaccine If You Take Rituximab?
ePosters - A retrospective audit of reduced-dose rituximab in rheumatoid arthritis
Treatment of rheumatoid arthritis with rituximab: An update and possible indications - ScienceDirect
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
Arthritis News: Lower Dose of Rituximab for RA Treatment Explored
JCM | Free Full-Text | Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
Rituximab protocols | Download Table
RITUXAN Dosage & Rx Info | Uses, Side Effects
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis | SpringerLink
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
Rituximab Infusion Dosing | RIABNI™ (rituximab-arrx)
Rituximab Biosimilar Truxima Now Available for Rheumatoid Arthritis - MPR
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis | NEJM
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
Algorithm for the use of rituximab in patients with RA. Broken line... | Download Scientific Diagram
